Tanguay, Robert M.
Université Laval
7 papers on CoChatORCID 0000-0002-3396-7547
Most cited papers
- Verified
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
Overturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.-N., Finegold, M., & Grompe, M. (1996) · Nature Genetics
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 549
- Verified
A Single Mutation of the Fumarylacetoacetate Hydrolase Gene in French Canadians with Hereditary Tyrosinemia Type I
Grompe, M., St.-Louis, M., Demers, S. I., Al-Dhalimy, M., Leclerc, B., & Tanguay, R. M. (1994) · New England Journal of Medicine
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 135
- Verified
Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.
Phaneuf, D., Lambert, M., Laframboise, R., Mitchell, G., Lettre, F., & Tanguay, R. M. (1992) · Journal of Clinical Investigation
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 84
- Verified
Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1.
Kelsey, G., Ruppert, S., Beermann, F., Grund, C., Tanguay, R. M., & Schutz, G. (1993) · Genes & Development
Metabolism and Genetic Disordersmelanin and skin pigmentation
Cited by 70
- Verified
Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia
Demers, S. I., Russo, P., Lettre, F., & Tanguay, R. M. (2003) · Human Pathology
Metabolism and Genetic DisordersPediatric Hepatobiliary Diseases and Treatments
Cited by 67
- Verified
Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I
St-Louis, M., Leclerc, B., Laine, J., K.Salo, M., Holmberg, C., & Tanguay, R. M. (1994) · Human Molecular Genetics
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 50
- Verified
Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model
Orejuela, D., Jorquera, R., Bergeron, A., Finegold, M. J., & Tanguay, R. M. (2008) · Journal of Hepatology
Metabolism and Genetic DisordersAmino Acid Enzymes and Metabolism
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free